Pfizer court fight could legalize Medicare copays and unleash ‘gold rush’ in sales
Three years ago, pharma giant Pfizer paid $24 million to settle federal allegations that it was paying kickbacks and inflating sales by reimbursing Medicare patients for out-of-pocket medication costs.
